[1]
Sulaymonov S.A., Nuriddinov N.N., Ochilov I.A., “DAPAGLIFLOZIN AS PART OF COMBINATION THERAPY IN COPD COMORBID WITH HEART FAILURE: EFFECTS ON PULMONARY, CARDIAC, RENAL AND ENDOTHELIAL FUNCTION”, imjrd, vol. 13, no. 4, pp. 76–86, Apr. 2026.